Confronting the ratio of these two biomarkers with a set of clinical, CT-scan and spirometric data could allow us to determine whether the IL-6/KL-6 ratio is a good candidate to better identify the phenotypic profiles of our patients with severe COVID-19. Here, MUC1 is linked to COVID-19.